Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat BCG Vaccinations in Pediatric Type 1 Diabetes
NCT05866536Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- May 2023
- Primary completion
- May 2031
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started May 2023; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05866536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05866536.